Laboratoire de Nanotechnologies Pharmaceutiques, faculté de pharmacie, Université de Montréal, CP6128, succursale Centre-ville, Montréal, QC, H3C 3J7, Canada.
Université de Lyon (UCBL), Biologie Tissulaire et Ingénierie Thérapeutique UMR 5305 et Vecteurs Colloïdaux et Transport Tissulaire, Institut des Sciences Pharmaceutiques et Biologiques, 8 avenue Rockefeller, 69373 Lyon, Cedex 08, France.
J Control Release. 2018 Feb 10;271:1-20. doi: 10.1016/j.jconrel.2017.12.019. Epub 2017 Dec 19.
Organogels are semi-solid systems with an organic liquid phase immobilized by a three-dimensional network composed of self-assembled, crosslinked or entangled gelator fibers. Organogel applications are various, including chemistry, pharmaceuticals, cosmetics, biotechnologies and food technology. In pharmacology, they are used as drug and vaccine delivery platforms for active ingredients via diverse routes such as transdermal, oral and parenteral. In a close past, their uses as drug delivery systems have been unfortunately hampered by the toxicity of the selected organic solvents. More recently, the synthesis of more biocompatible organogels has strengthened the development of several biomedical and pharmaceutical applications. This review provides a global view of organogels, such as nature, syntheses, characterizations and properties. An emphasis is placed on the most recent technologies used in the design of organogels as potential controlled delivery systems. A particular attention is provided to their newest therapeutic applications.
有机凝胶是一种半固态系统,其中有机液相被由自组装、交联或缠结的凝胶剂纤维组成的三维网络固定。有机凝胶的应用多种多样,包括化学、制药、化妆品、生物技术和食品技术。在药理学中,它们被用作通过多种途径(如透皮、口服和肠胃外途径)输送药物和疫苗的平台,这些途径的活性成分。在不久的过去,由于所选有机溶剂的毒性,它们作为药物传递系统的用途不幸受到阻碍。最近,更具生物相容性的有机凝胶的合成增强了几种生物医学和制药应用的发展。本综述提供了对有机凝胶的全面了解,例如性质、合成、表征和性质。重点介绍了在设计作为潜在控制释放系统的有机凝胶中使用的最新技术。特别关注它们的最新治疗应用。